Abstract
TNF-related apoptosis-inducing ligand (TRAIL/Apo- 2L), a newly identified member of the TNF family promotes apoptosis by binding to the transmembrane receptors (TRAIL-R1/DR4 and TRAIL-R2/ DR5). TRAIL known to activate NF-κB in number of tumor cells including A549 (wt p53) and NCI- H1299 (null p53) lung cancer cells exerts relatively selective cytotoxic affects to the human tumor cell lines without much effect on the normal cells. We set out to identify an agent that would sensitize lung cancer cells to TRAIL-induced apoptosis through inhibition of NF-κB activation. We found that triptolide, an oxygenated diterpene extracted and purified from the Chinese herb Tripterygium wilfordii sensitized A549 and NCI-H1299 cells to TRAIL-induced apoptosis through inhibition of NF-κB activation. Pretreatment with MG132 which is a well-known NF-κB inhibitor by blocking degradation of IκB α also greatly sensitized lung cancer cells to TRAIL-induced apoptosis. Triptolide did not block DNA binding of NF-κB activated by TRAIL as in the case of TNF-α. It has been already proven that triptolide blocks transactivation of p65 which plays a key role in NF-κB activation. These observations suggest that triptolide may be a potentially useful drug to enhance TRAIL-induced tumor killing in lung cancer.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Lee, K., Park, J., Jee, Y. et al. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activation. Exp Mol Med 34, 462–468 (2002). https://doi.org/10.1038/emm.2002.64
Published:
Issue Date:
DOI: https://doi.org/10.1038/emm.2002.64
Keywords
This article is cited by
-
Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts
Oncogenesis (2020)
-
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
Cell Death & Disease (2017)
-
Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy
Scientific Reports (2017)
-
Anticancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells
Molecular and Cellular Biochemistry (2014)
-
Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas
Medical Oncology (2014)